References
- Acharya, I. L., C. U. Lowe, R. Thapa, V. L. Gurubacharya, M. B. Shrestha, M. Cadoz, D. Schulz, J. Armand, D. A. Bryla, B. Trollfors, T. Cramton, R. Schneerson, and J. B. Robbins. 1987. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi: A preliminary report. N. Engl. J. Med. 317: 1101-1104 https://doi.org/10.1056/NEJM198710293171801
- Ackers, M. L., N. D. Puhr, R. V. Tauxe, and E. D. Mintz. 2000. Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States: Antimicrobial resistance on the rise. JAMA 283: 2668
- Beiger, E. M., D. R. Burwen, P. Haber, and R. Ball. 2004. Postmarketing safety surveillance for typhoid fever vaccines from the vaccine adverse event reporting system, July 1990 through June 2002. Clin. Infect. Dis. 38: 771-779 https://doi.org/10.1086/381548
- Bodhidatta, L., D. N. Taylor, U. Thisyakom, and P. Echeverria. 1987. Control of typhoid fever in Bangkok, Thailand, by annual immunization of school children with parenteral typhoid vaccine. Rev. Infect. Dis. 9: 841-845 https://doi.org/10.1093/clinids/9.4.841
- Center for Disease Control and Prevention. 1994. Typhoid immunization recommendation of the Advisory Committee on Immunization Practices (ACIP). MMWR 43(RR-14): 1-6
- Centers for Disease Control and Prevention. High priority potential bioterrorism agents list. Available at http://www.bt.cdc.gov/Agent/agentlist.asp. Accessed 12 January 2004
- Engels, E. A., M. E. Falagas, J. Lau, and M. L. Bennish. 1998. Typhoid fever vaccines: A meta-analysis of studies on efficacy and toxicity. BMJ 316: 110-116 https://doi.org/10.1136/bmj.316.7125.110
- Joo, J. H. and J. W. Yun. 2005. Structural and molecular characterization of extracellular polysaccharides produced by a new fungal strain, Trichoderma erinaceum DG-312. J. Microbiol. Biotechnol. 15: 1250-1257
- Keddy, K. H., K. P. Klugman, C. F. Hansford, C. Blonde, and N. B. Nancy. 1999. Persistence of antibodies to the Salmonella typhi, Vi capsular polysacchride vaccine in South African school children 10 years after immunization. Vaccine 17: 110-113 https://doi.org/10.1016/S0264-410X(98)00160-1
- Keitel, W. A., N. L. Bond, J. M. Zahradnik, T. A. Cramton, and J. B. Robbins. 1994. Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines. Vaccine 12: 195-199 https://doi.org/10.1016/0264-410X(94)90194-5
- Klugman, K. P., H. J. Koornhof, J. B. Robbins, and N. N. Le Cam. 1996. Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine 14: 435-438 https://doi.org/10.1016/0264-410X(95)00186-5
- Korea Center for Disease Control and Prevention. Communicable disease information. 2000. Available at http://dis.mohw.go.kr/information/info.asp
-
Kroon, F. P., J. T. V. Dissel, E. Ravensbergen, P. H. Nibbering, and R. V. Furth. 1999. Impaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against Salmonella typhi (Typhim-
$Vi^{\circledR}$ ). Vaccine 17: 2941-2945 https://doi.org/10.1016/S0264-410X(99)00167-X - Landy, M. and E. Lamb. 1953. Estimation of Vi antibody employing erythrocytes treated with purified Vi antigen. Proc. Soc. Exp. Biol. Med. 82: 593-598
- Maskalyk, J. 2003. Typhoid fever. CMAJ 169: 132
- Mermin, J. H., R. Villar, J. Carpenter, L. Roberts, A. Samaridden, L. Gasanova, S. Lomakina, C. Bopp, L. Hutwagner, P. Mead, B. Ross, and E. D. Mintz. 1999. A massive epidemic of multidrug-resistant typhoid fever in Tajikistan associated with consumption of municipal water. J. Infect. Dis. 179: 1416-1422 https://doi.org/10.1086/314766
- Murdoch, D. A., N. A. Banatvala, B. I. Shoismatulloev, L. R. Ward, and E. J. Threlfall. 1988. Epidemic ciprofloxacin-resistant Salmonella typhi in Tajikistan. Lancet 351: 339
- Murphy, J. R., L. Grez, L. Schlesinger, C. Ferreccio, S. Baqar, C. Munoz, S. S. Wasserman, G. Losonsky, J. G. Olson, and M. M. Levine. 1991. Immunogenicity of Salmonella typhi Ty21a vaccine for young children. Infect. Immun. 59: 4291-4293
- Olsen, S. J., S. C. Bleasdale, A. R. Magnano, C. Landrigan, B. H. Holland, R. V. Tauxe, E. D. Mintz, and S. Luby. 2003. Outbreaks of typhoid fever in the United States, 1960-99. Epidemiol. Infect. 130: 13-21
- Panchanathan, V., S. Kumar, W. Yeap, S. Devi, R. Ismail, S. Sarijan, S. M. Sam, Z. Jusoh, S. Nordin, D. Leboulleux, and T. Pang. 2001. Comparison of safety and immunogenicity of a Vi polysaccharide typhoid vaccine with a whole-cell killed vaccine in Malaysian Air Force recruits. Bull. World Health Organ. 79: 811-817
- Park, J. W., W. S. Shin, M. W. Kang, D. K. Ko, and J. H. Kang. 1991. Safety and immunogenicity of the typhoid Vi capsular polysaccharide vaccine. Kor. Soc. Infec. Dis. 23: 145-153
- Plotkin, S. A. and N. Bouveret-Le Cam. 1995. A new typhoid vaccine composed of the Vi capsular polysaccharide. Arch. Intern. Med. 155: 2293-2299 https://doi.org/10.1001/archinte.155.21.2293
- Sabitha, P., M. R. P. Adhikari, A. Chowdary, M. Prabhu, M. Soofi, M. Shetty, A. Kamath, S. S. Lokaranjan, and S. S. Bangera. 2004. Comparison of the immunogenicity and safety of two different brands of Salmonella typhi Vi capsular polysaccharide vaccine. Indian J. Med. Sci. 58: 141-149
- Sohn, Y. M., J. H. Kim, and D. B. Gae. 1993. Immunogenicity and safety of the Typhoid Vi capsular polysaccharide vaccine (Typhovax) in children. J. Korean Soc. Chemother. 11: 185-191
- Tacket, C. O., C. Ferrecio, J. B. Robbins, C. M. Tsai, D. Schulz, M. Cadoz, A. Goudeau, and M. M. Levine. 1986. Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines. J. Infect. Dis. 154: 342-345 https://doi.org/10.1093/infdis/154.2.342
- Tacket, C. O., M. L. Levin, and J. B. Robbins. 1988. Persistance of antibody titers three years after vaccination with Vi polysaccharide vaccine against typhoid fever. Vaccine 6: 307-308 https://doi.org/10.1016/0264-410X(88)90175-2
- Torok, T. J., R. V. Tauxe, R. P. Wise, J. R. Livengood, R. Sokolow, S. Mauvais, K. A. Birkness, M. R. Skeels, J. M. Horan, and L. R. Foster. 1997. A large community outbreak of salmonellosis caused by intentional contamination cf restaurant salad bars. JAMA 278: 389-395 https://doi.org/10.1001/jama.278.5.389
- Wong, K. H., J. C. Feeley, R. S. Northrup, and M. E. Forlines. 1974. Vi antigen from Salmonella typhosa and immunity against typhoid fever. I. Isolation and immunologic properties in animals. Infect. Immun. 9: 348-353
- Yang, H. H., C. G. Wu, G. Z. Xie, Q. W. Gu, B. R. Wang, L. Y. Wang, H. F. Wang, Z. S. Ding, Y. Yang, W. S. Tar., W. Y. Wang, X. C. Wang, M. Qin, J. H. Wang, H. A. Tang, X. M. Jiang, Y. H. Li, M. L. Wang, S. L. Zhang, and G. L. Li. 2001. Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China. Bull. World Health Organ. 79: 625-631